NYSE:ABC

AmerisourceBergen (ABC) Stock Forecast, Price & News

Compare

Today's Range: N/A
50-Day Range: $177.76
▼
$193.39
52-Week Range: N/A

Volume: 806,000 shs
Average Volume: 1.43 million shs
Market Capitalization: $36.39 billion

P/E Ratio: 21.92
Dividend Yield: 1.08%
Price Target: $189.36

AmerisourceBergen MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.86 Rating Score
Upside/Downside: ∞ Upside
$189.36 Price Target
Short Interest: Bearish
4.16% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -1.55
Upright™ Environmental Score
News Sentiment: 0.86
Based on 5 Articles This Week
Insider Trading: Selling Shares
$253.98 M Sold Last Quarter
Proj. Earnings Growth: 7.47%
From $11.92 to $12.81 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.01 out of 5 stars

Medical Sector

30th out of 976 stocks

Drugs, Proprietaries, & Sundries Industry

2nd out of 8 stocks

3.4

Analyst's Opinion

Consensus Rating
AmerisourceBergen has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 12 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $189.36, AmerisourceBergen has a forecasted upside of ∞ from its current price of $0.00.
Amount of Analyst Coverage
AmerisourceBergen has only been the subject of 2 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
4.16% of the float of AmerisourceBergen has been sold short.
Short Interest Ratio / Days to Cover
AmerisourceBergen has a short interest ratio ("days to cover") of 4.1.
Change versus previous month
Short interest in AmerisourceBergen has recently increased by 79.08%, indicating that investor sentiment is decreasing significantly.

4.2

Dividend Strength

Dividend Yield
AmerisourceBergen pays a meaningful dividend of 1.08%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
AmerisourceBergen has been increasing its dividend for 18 years.
Dividend Coverage
The dividend payout ratio of AmerisourceBergen is 23.63%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 15.14% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.

2.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
AmerisourceBergen has received a 25.43% net impact score from Upright. AmerisourceBergen seems to create the most significant positive value in categories "Taxes", "Physical diseases", and "Jobs". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Management consulting for the pharmaceutical industry", "Health care management software", and "Wholesale of pharmaceuticals" products. See details.
Environmental Sustainability
The Environmental Impact score for AmerisourceBergen is -1.55.

1.6

News and Social Media Coverage

News Sentiment
AmerisourceBergen has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for AmerisourceBergen this week, compared to 6 articles on an average week.
Search Interest
Only 13 people have searched for ABC on MarketBeat in the last 30 days. This is a decrease of -13% compared to the previous 30 days.
MarketBeat Follows
Only 6 people have added AmerisourceBergen to their MarketBeat watchlist in the last 30 days. This is a decrease of -14% compared to the previous 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, AmerisourceBergen insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $253,978,545.00 in company stock.
Percentage Held by Insiders
20.10% of the stock of AmerisourceBergen is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
93.12% of the stock of AmerisourceBergen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for AmerisourceBergen are expected to grow by 7.47% in the coming year, from $11.92 to $12.81 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of AmerisourceBergen is 21.92, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 118.92.
Price to Earnings Ratio vs. Sector
The P/E ratio of AmerisourceBergen is 21.92, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 122.15.
Price to Earnings Growth Ratio
AmerisourceBergen has a PEG Ratio of 1.79. PEG Ratios above 1 indicate that a company could be overvalued.

See Top Rated MarketRank™ Stocks Here

About AmerisourceBergen (NYSE:ABC) Stock

AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

September 27, 2023 | americanbankingnews.com

AmerisourceBergen Co. (NYSE:ABC) Receives Average Recommendation of "Moderate Buy" from Brokerages

September 23, 2023 | americanbankingnews.com

StockNews.com Initiates Coverage on AmerisourceBergen (NYSE:ABC)

September 27, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

September 8, 2023 | finance.yahoo.com

Why AmerisourceBergen (COR) is a Top Growth Stock for the Long-Term

September 3, 2023 | fool.com

Cencora (NYSE: ABC)

August 31, 2023 | msn.com

Amerisource Bergen (ABC) Price Target Increased by 5.31% to 213.76

August 30, 2023 | msn.com

AmerisourceBergen changes name to Cencora, ticker to COR

August 30, 2023 | finance.yahoo.com

AmerisourceBergen's name change becomes official

September 27, 2023 | Chaikin Analytics (Ad)

His system isolated NVIDIA - Here's His Next Buy.

Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.

August 30, 2023 | finance.yahoo.com

AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care

August 28, 2023 | msn.com

Tivic To Offer Sinus Pain Relief Device In Retail Pharmacy Marketplace Via AmerisourceBergen's Platform

August 25, 2023 | benzinga.com

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today

August 21, 2023 | finance.yahoo.com

Ozempic, Weight-Loss Drugs Carry Costly, Complicated Logistics

August 17, 2023 | stocknews.com

Walgreens Boots Alliance (WBA), CVS Health (CVS), and Rite Aid (RAD): Buy, Hold or Sell?

August 15, 2023 | marketwatch.com

AmerisourceBergen Corp. stock outperforms competitors despite losses on the day

August 15, 2023 | reuters.com

Cardinal Health raises 2024 profit forecast on drug distribution strength

August 15, 2023 | finance.yahoo.com

AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors

August 12, 2023 | markets.businessinsider.com

J.P. Morgan Reaffirms Their Buy Rating on AmerisourceBergen (ABC)

August 10, 2023 | msn.com

Amerisource Bergen (ABC) Declares $0.48 Dividend

August 8, 2023 | msn.com

TD Cowen Maintains Amerisource Bergen (ABC) Outperform Recommendation

August 6, 2023 | finance.yahoo.com

AmerisourceBergen Corporation (NYSE:ABC) Passed Our Checks, And It's About To Pay A US$0.48 Dividend

August 4, 2023 | msn.com

Walgreens sells AmerisourceBergen stock for ~$1.9B proceeds

August 4, 2023 | nasdaq.com

Morgan Stanley Maintains Amerisource Bergen (ABC) Equal-Weight Recommendation

August 3, 2023 | finance.yahoo.com

Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds

August 3, 2023 | finance.yahoo.com

AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase

August 3, 2023 | markets.businessinsider.com

Bank of America Securities Reaffirms Their Buy Rating on AmerisourceBergen (ABC)

August 3, 2023 | finance.yahoo.com

UPDATE 1-AmerisourceBergen sees upbeat annual profit on specialty pharma strength

See More Headlines

Receive ABC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AmerisourceBergen and its competitors with MarketBeat's FREE daily newsletter.

ABC Company Calendar

Last Earnings: 8/02/2023
Ex-Dividend for 8/28 Dividend: 8/10/2023
Dividend Payable: 8/28/2023
Today: 9/27/2023
Fiscal Year End: 9/30/2023
Next Earnings (Estimated): 11/02/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Drugs, proprietaries, & sundries
Sub-Industry: Health Care Distributors
Sector: Medical
Current Symbol: NYSE:ABC
CUSIP: 03073E10
CIK: 1140859
Web: www.amerisourcebergen.com
Phone: (610) 727-7000
Fax: 800-640-5221
Employees: 44,000
Year Founded: 2001

Price Target and Rating

Average Stock Price Forecast: $189.36
High Stock Price Forecast: $215.00
Low Stock Price Forecast: $169.00
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.86
Research Coverage: 14 Analysts

Profitability

EPS (Most Recent Fiscal Year): $8.21
Trailing P/E Ratio: 21.92
Forward P/E Ratio: N/A
P/E Growth: 1.79
Net Income: $1.70 billion
Net Margins: 0.66%
Pretax Margin: 0.82%
Return on Equity: 612.69%
Return on Assets: 4.12%

Debt

Debt-to-Equity Ratio: 4.51
Current Ratio: 0.88
Quick Ratio: 0.52

Sales & Book Value

Annual Sales: $254.43 billion
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 11.98
Book Value: $4.56 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 202,175,000
Free Float: 161,538,000
Market Cap: $36.39 billion
Optionable: Optionable
Beta: 0.56

Social Links

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Steven H. Collis (Age 62)
Chairman, Pres & CEO
Comp: $5.49M

Mr. James F. Cleary Jr. (Age 60)
Exec. VP & CFO
Comp: $2.12M

Dr. Robert P. Mauch Ph.D. (Age 56)
PharmD, Exec. VP & COO
Comp: $2.32M

Ms. Gina K. Clark (Age 66)
Exec. VP and Chief Communications & Admin. Officer
Comp: $1.68M

Ms. Silvana Battaglia (Age 55)
Exec. VP & Chief HR Officer
Comp: $1.58M

Mr. Lazarus Krikorian (Age 58)
Sr. VP, Chief Accounting Officer & Corp. Controller

Bennett S. Murphy
Sr. VP of Investor Relations

Ms. Kathy H. Gaddes (Age 60)
Exec. VP & Chief Compliance Officer

Ms. Elizabeth S. Campbell (Age 48)
Exec. VP & Chief Legal Officer

Mr. John G. Chou (Age 67)
Exec. VP and Special Advisor to the Chairman & CEO

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ABC Stock - Frequently Asked Questions

Should I buy or sell AmerisourceBergen stock right now?: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ABC shares.
View ABC analyst ratings or view top-rated stocks.
What is AmerisourceBergen's stock price forecast for 2023?: 14 Wall Street analysts have issued 12-month price objectives for AmerisourceBergen's shares. Their ABC share price forecasts range from $169.00 to $215.00. On average, they anticipate the company's share price to reach $189.36 in the next year.
View analysts price targets for ABC or view top-rated stocks among Wall Street analysts.
When is AmerisourceBergen's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our ABC earnings forecast.
How were AmerisourceBergen's earnings last quarter?: AmerisourceBergen Co. (NYSE:ABC) announced its earnings results on Wednesday, August, 2nd. The company reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.83 by $0.09. The company earned $66.95 billion during the quarter, compared to analysts' expectations of $63.93 billion. AmerisourceBergen had a trailing twelve-month return on equity of 612.69% and a net margin of 0.66%. AmerisourceBergen's quarterly revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.62 EPS.
Read the conference call transcript.
How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?: AmerisourceBergen announced a quarterly dividend on Wednesday, August 2nd. Shareholders of record on Friday, August 11th will be given a dividend of $0.485 per share on Monday, August 28th. This represents a $1.94 annualized dividend and a dividend yield of ∞. The ex-dividend date is Thursday, August 10th.
Read our dividend analysis for ABC.
What ETFs hold AmerisourceBergen's stock?: ETFs with the largest weight of AmerisourceBergen (NYSE:ABC) stock in their portfolio include VanEck Pharmaceutical ETF (PPH), Natixis Vaughan Nelson Mid Cap ETF (VNMC), Vesper U.S. Large Cap Short-Term Reversal Strategy ETF (UTRN), AdvisorShares Focused Equity ETF (CWS), First Trust Consumer Staples AlphaDEX Fund (FXG), Adaptive Core ETF (RULE), First Trust Dorsey Wright Momentum & Low Volatility ETF (DVOL) and BlackRock Future Health ETF (BMED).
Is AmerisourceBergen a good dividend stock?: AmerisourceBergen (NYSE:ABC) pays an annual dividend of $1.94 per share and currently has a dividend yield of 1.08%. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 23.63%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ABC will have a dividend payout ratio of 15.14% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ABC.
What guidance has AmerisourceBergen issued on next quarter's earnings?: AmerisourceBergen updated its FY23 earnings guidance on Wednesday, August, 2nd. The company provided EPS guidance of $11.85-11.95 for the period, compared to the consensus estimate of $11.86. The company issued revenue guidance of ~$257.67 billion, compared to the consensus revenue estimate of $255.31 billion.

What is Steve Collis' approval rating as AmerisourceBergen's CEO?: 447 employees have rated AmerisourceBergen Chief Executive Officer Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among the company's employees.
What other stocks do shareholders of AmerisourceBergen own?: Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Pfizer (PFE).
What is AmerisourceBergen's stock symbol?: AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."
Who are AmerisourceBergen's major shareholders?: AmerisourceBergen's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.42%), State Street Corp (3.83%), JPMorgan Chase & Co. (3.45%), Boston Partners (2.45%), Geode Capital Management LLC (1.73%) and Bessemer Group Inc. (1.56%). Insiders that own company stock include Elizabeth S Campbell, Gina Clark, Henry Wadsworth Mcgee III, John G Chou, John G Chou, Lazarus Krikorian, Leslie E Donato, Robert P Mauch, Silvana Battaglia, Steven H Collis and Walgreens Boots Alliance, Inc.
View institutional ownership trends.
How do I buy shares of AmerisourceBergen?: Shares of ABC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
How much money does AmerisourceBergen make?: AmerisourceBergen (NYSE:ABC) has a market capitalization of $0.00 and generates $254.43 billion in revenue each year. The company earns $1.70 billion in net income (profit) each year or $8.21 on an earnings per share basis.
How many employees does AmerisourceBergen have?: The company employs 44,000 workers across the globe.
Does AmerisourceBergen have any subsidiaries?: The following companies are subsidiares of AmerisourceBergen: AB Singapore Investments Pte Ltd, AB UK Holdings Ltd, ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group GmbH, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Sourcing LLC, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Physician Networks L.L.C., IntrinsiQ, Lash Group, MWI Veterinary Supply, Network for Medical Communications & Research, PMSI, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, Wight Nederland Holdco 2 BV, World Courier, World Courier Group S.à r.l., and Xcenda.
Read More
How can I contact AmerisourceBergen?: AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The official website for the company is www.amerisourcebergen.com. The company can be reached via phone at (610) 727-7000, via email at investorrelations@amerisourcebergen.com, or via fax at 800-640-5221.

This page (NYSE:ABC) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

AmerisourceBergen (ABC) Stock Forecast, Price & News

AmerisourceBergen MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About AmerisourceBergen (NYSE:ABC) Stock

ABC Stock News Headlines

ABC Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

ABC Stock - Frequently Asked Questions

Overall MarketRank^™